2,144
Views
18
CrossRef citations to date
0
Altmetric
REPORTS

A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)

, , , , , & show all
Pages 1415-1424 | Received 22 Jun 2014, Accepted 25 Aug 2014, Published online: 15 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Martin J. Scott, Amanda Jowett, Martin Orecchia, Peter Ertl, Larissa Ouro-Gnao, Julia Ticehurst, David Gower, John Yates, Katie Poulton, Carol Harris, Michael J. Mullin, Kathrine J. Smith, Alan P. Lewis, Nick Barton, Michael L. Washburn & Ruud de Wildt. (2020) Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies. mAbs 12:1.
Read now
Bas van der Woning, Gitte De Boeck, Christophe Blanchetot, Vladimir Bobkov, Alex Klarenbeek, Michael Saunders, Magali Waelbroeck, Toon Laeremans, Jan Steyaert, Anna Hultberg & Hans De Haard. (2016) DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops. mAbs 8:6, pages 1126-1135.
Read now

Articles from other publishers (16)

Nam Hyuk Kim, Sumin Kang, Ga Hyeon Park, Goeun Shim, Tae Hyun Kang & Yeon Gyu Yu. (2022) A robust antibody discovery platform for difficult‐to‐express G protein‐coupled receptors. Protein Science 32:1.
Crossref
Xiaojie Shi, Yue Wan, Nan Wang, Jiangchao Xiang, Tao Wang, Xiaofeng Yang, Ju Wang, Xuxue Dong, Liang Dong, Lei Yan, Yu Li, Lili Liu, Shinchen Hou, Zhenwei Zhong, Ian A. Wilson, Bei Yang, Guang Yang & Richard A. Lerner. (2021) Selection of a picomolar antibody that targets CXCR2-mediated neutrophil activation and alleviates EAE symptoms. Nature Communications 12:1.
Crossref
Georgina To'a Salazar, Ziyi Huang, Ningyan Zhang, Xue-Guang Zhang & Zhiqiang An. (2021) Antibody Therapies Targeting Complex Membrane Proteins. Engineering 7:11, pages 1541-1551.
Crossref
Amod Kulkarni, Evelína Mochnáčová, Petra Majerova, Ján Čurlík, Katarína Bhide, Patrícia Mertinková & Mangesh Bhide. (2020) Single Domain Antibodies Targeting Receptor Binding Pockets of NadA Restrain Adhesion of Neisseria meningitidis to Human Brain Microvascular Endothelial Cells. Frontiers in Molecular Biosciences 7.
Crossref
Elham Ghamghami, Marjan Abri Aghdam, Mohammad Reza Tohidkia, Asadollah Ahmadikhah, Morteza Khanmohammadi, Tayebeh Mehdipour, Ahad Mokhtarzadeh & Behzad Baradaran. (2020) Optimization of Tris/EDTA/Sucrose (TES) periplasmic extraction for the recovery of functional scFv antibodies. AMB Express 10:1.
Crossref
Man-Seok Ju & Sang Taek Jung. (2020) Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies. International Journal of Molecular Sciences 21:21, pages 8240.
Crossref
Conor McMahon, Dean P. StausLaura M. Wingler, Jialu WangMeredith A. Skiba, Matthias Elgeti, Wayne L. HubbellHoward A. RockmanAndrew C. Kruse & Robert J. Lefkowitz. (2020) Synthetic nanobodies as angiotensin receptor blockers. Proceedings of the National Academy of Sciences 117:33, pages 20284-20291.
Crossref
Roger Dodd, Darren J. Schofield, Trevor Wilkinson & Zachary T. Britton. (2020) Generating therapeutic monoclonal antibodies to complex multi-spanning membrane targets: Overcoming the antigen challenge and enabling discovery strategies. Methods 180, pages 111-126.
Crossref
Chien-Chiao Huang, Kai-Wen Cheng, Yuan-Chin Hsieh, Wen-Wei Lin, Chiu-Min Cheng, Shyng-Shiou F. Yuan, I-Ju Chen, Yi-An Cheng, Yun-Chi Lu, Bo-Cheng Huang, Yi-Ching Tung & Tian-Lu Cheng. (2019) Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein. Scientific Reports 9:1.
Crossref
Vidyanand Anaparti. (2018) Anti-GPCR Antibodies. Materials and Methods 8.
Crossref
Zachary T Britton, Timothy B London, Jeffrey Carrell, Bhupinder Dosanjh, Trevor Wilkinson, Michael A Bowen, Herren Wu, William F Dall’Acqua, Marcello Marelli & Yariv Mazor. (2018) Tag-on-Demand: exploiting amber codon suppression technology for the enrichment of high-expressing membrane protein cell lines. Protein Engineering, Design and Selection 31:10, pages 389-398.
Crossref
Roger B. Dodd, Trevor Wilkinson & Darren J. Schofield. (2018) Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies. BioDrugs 32:4, pages 339-355.
Crossref
Catherine J. Hutchings, Markus Koglin, William C. Olson & Fiona H. Marshall. (2017) Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nature Reviews Drug Discovery 16:11, pages 787-810.
Crossref
Julie A. Douthwaite, Donna K. Finch, Tomas Mustelin & Trevor C.I. Wilkinson. (2017) Development of therapeutic antibodies to G protein-coupled receptors and ion channels: Opportunities, challenges and their therapeutic potential in respiratory diseases. Pharmacology & Therapeutics 169, pages 113-123.
Crossref
Trevor C.I. Wilkinson. (2016) Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels. Biochemical Society Transactions 44:3, pages 831-837.
Crossref
Jeong Ho Hwang, Sang Eun Kim, Sung Han Jung, Young Kyu Kim, Yoon Berm Kim & Hoon Taek Lee. (2015) Characterization of monoclonal antibodies against porcine pulmonary alveolar macrophages of gnotobiotic miniature swine. Biochemical and Biophysical Research Communications 461:2, pages 427-434.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.